Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement with Saniona, a Denmark-based clinical-stage biopharmaceutical company, to develop and commercialize ...
Why ACADIA Pharmaceuticals might be on your watchlist ACADIA Pharmaceuticals (ACAD) has drawn fresh attention after recent trading, with the share price around $22.20 and mixed returns across ...
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of GSK (GSK) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more ...
View ACADIA Pharmaceuticals Inc. ACAD stock quote prices, financial information, real-time forecasts, and company news from CNN.
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Kamada (KMDA) or Acadia Pharmaceuticals (ACAD). But which of these two stocks is more ...
Fintel reports that on March 25, 2026, B of A Securities upgraded their outlook for ACADIA Pharmaceuticals (NasdaqGS:ACAD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results